These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 25037676)

  • 1. Comparison of the use of hemodynamic support in patients ≥80 years versus patients <80 years during high-risk percutaneous coronary interventions (from the Multicenter PROTECT II Randomized Study).
    Pershad A; Fraij G; Massaro JM; David SW; Kleiman NS; Denktas AE; Wilson BH; Dixon SR; Ohman EM; Douglas PS; Moses JW; O'Neill WW
    Am J Cardiol; 2014 Sep; 114(5):657-64. PubMed ID: 25037676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective, randomized clinical trial of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump in patients undergoing high-risk percutaneous coronary intervention: the PROTECT II study.
    O'Neill WW; Kleiman NS; Moses J; Henriques JP; Dixon S; Massaro J; Palacios I; Maini B; Mulukutla S; Dzavík V; Popma J; Douglas PS; Ohman M
    Circulation; 2012 Oct; 126(14):1717-27. PubMed ID: 22935569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump on prognostically important clinical outcomes in patients undergoing high-risk percutaneous coronary intervention (from the PROTECT II randomized trial).
    Dangas GD; Kini AS; Sharma SK; Henriques JP; Claessen BE; Dixon SR; Massaro JM; Palacios I; Popma JJ; Ohman M; Stone GW; O'Neill WW
    Am J Cardiol; 2014 Jan; 113(2):222-8. PubMed ID: 24527505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating the learning curve in the prospective Randomized Clinical Trial of hemodynamic support with Impella 2.5 versus Intra-Aortic Balloon Pump in patients undergoing high-risk percutaneous coronary intervention: a prespecified subanalysis of the PROTECT II study.
    Henriques JP; Ouweneel DM; Naidu SS; Palacios IF; Popma J; Ohman EM; O'Neill WW
    Am Heart J; 2014 Apr; 167(4):472-479.e5. PubMed ID: 24655695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective feasibility trial investigating the use of the Impella 2.5 system in patients undergoing high-risk percutaneous coronary intervention (The PROTECT I Trial): initial U.S. experience.
    Dixon SR; Henriques JP; Mauri L; Sjauw K; Civitello A; Kar B; Loyalka P; Resnic FS; Teirstein P; Makkar R; Palacios IF; Collins M; Moses J; Benali K; O'Neill WW
    JACC Cardiovasc Interv; 2009 Feb; 2(2):91-6. PubMed ID: 19463408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term clinical outcomes after percutaneous coronary intervention for ostial/mid-shaft lesions versus distal bifurcation lesions in unprotected left main coronary artery: the DELTA Registry (drug-eluting stent for left main coronary artery disease): a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.
    Naganuma T; Chieffo A; Meliga E; Capodanno D; Park SJ; Onuma Y; Valgimigli M; Jegere S; Makkar RR; Palacios IF; Costopoulos C; Kim YH; Buszman PP; Chakravarty T; Sheiban I; Mehran R; Naber C; Margey R; Agnihotri A; Marra S; Capranzano P; Leon MB; Moses JW; Fajadet J; Lefevre T; Morice MC; Erglis A; Tamburino C; Alfieri O; Serruys PW; Colombo A
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1242-9. PubMed ID: 24355114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylactic use of intra-aortic balloon pump for high-risk percutaneous coronary intervention: will the Impella LP 2.5 device show superiority in a clinical randomized study?
    Syed AI; Kakkar A; Torguson R; Li Y; Ben-Dor I; Collins SD; Lemesle G; Maluenda G; Xue Z; Scheinowitz M; Kaneshige K; Satler LF; Kent KM; Suddath WO; Pichard AD; Lindsay J; Waksman R
    Cardiovasc Revasc Med; 2010; 11(2):91-7. PubMed ID: 20347798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elective intra-aortic balloon counterpulsation during high-risk percutaneous coronary intervention: a randomized controlled trial.
    Perera D; Stables R; Thomas M; Booth J; Pitt M; Blackman D; de Belder A; Redwood S;
    JAMA; 2010 Aug; 304(8):867-74. PubMed ID: 20736470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized controlled trial of preoperative intra-aortic balloon pump in coronary patients with poor left ventricular function undergoing coronary artery bypass surgery*.
    Ranucci M; Castelvecchio S; Biondi A; de Vincentiis C; Ballotta A; Varrica A; Frigiola A; Menicanti L;
    Crit Care Med; 2013 Nov; 41(11):2476-83. PubMed ID: 23921278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radial versus femoral approach comparison in percutaneous coronary intervention with intraaortic balloon pump support: the RADIAL PUMP UP registry.
    Romagnoli E; De Vita M; Burzotta F; Cortese B; Biondi-Zoccai G; Summaria F; Patrizi R; Lanzillo C; Lucci V; Cavazza C; Tarantino F; Sangiorgi GM; Lioy E; Crea F; Rao SV; Trani C
    Am Heart J; 2013 Dec; 166(6):1019-26. PubMed ID: 24268216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimizing rotational atherectomy in high-risk percutaneous coronary interventions: insights from the PROTECT ΙΙ study.
    Cohen MG; Ghatak A; Kleiman NS; Naidu SS; Massaro JM; Kirtane AJ; Moses J; Magnus Ohman E; Džavík V; Palacios IF; Heldman AW; Popma JJ; O'Neill WW
    Catheter Cardiovasc Interv; 2014 Jun; 83(7):1057-64. PubMed ID: 24174321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between intraprocedural thrombotic events and adverse outcomes after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction (a Harmonizing Outcomes With RevasculariZatiON and Stents in Acute Myocardial Infarction [HORIZONS-AMI] Substudy).
    Kirtane AJ; Sandhu P; Mehran R; McEntegart M; Cristea E; Brener SJ; Xu K; Fahy M; Généreux P; Wessler JD; Stone GW
    Am J Cardiol; 2014 Jan; 113(1):36-43. PubMed ID: 24169019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of 30-day and 5-year outcomes of percutaneous coronary intervention versus coronary artery bypass grafting in patients aged≤50 years (the Coronary aRtery diseAse in younG adultS Study).
    Biancari F; Gudbjartsson T; Heikkinen J; Anttila V; Mäkikallio T; Jeppsson A; Thimour-Bergström L; Mignosa C; Rubino AS; Kuttila K; Gunn J; Wistbacka JO; Teittinen K; Korpilahti K; Onorati F; Faggian G; Vinco G; Vassanelli C; Ribichini F; Juvonen T; Axelsson TA; Sigurdsson AF; Karjalainen PP; Mennander A; Kajander O; Eskola M; Ilveskoski E; D'Oria V; De Feo M; Kiviniemi T; Airaksinen KE
    Am J Cardiol; 2014 Jul; 114(2):198-205. PubMed ID: 24878127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Supported high-risk percutaneous coronary intervention with the Impella 2.5 device the Europella registry.
    Sjauw KD; Konorza T; Erbel R; Danna PL; Viecca M; Minden HH; Butter C; Engstrøm T; Hassager C; Machado FP; Pedrazzini G; Wagner DR; Schamberger R; Kerber S; Mathey DG; Schofer J; Engström AE; Henriques JP
    J Am Coll Cardiol; 2009 Dec; 54(25):2430-4. PubMed ID: 20082934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of prophylactic intra-aortic balloon pump in high-risk patients undergoing percutaneous coronary intervention.
    Mishra S; Chu WW; Torguson R; Wolfram R; Deible R; Suddath WO; Pichard AD; Satler LF; Kent KM; Waksman R
    Am J Cardiol; 2006 Sep; 98(5):608-12. PubMed ID: 16923445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility and long-term safety of elective Impella-assisted high-risk percutaneous coronary intervention: a pilot two-centre study.
    Burzotta F; Paloscia L; Trani C; Mascellanti M; Mongiardo R; Materazzo G; Niccoli G; Di Marco M; Leone AM; Porto I; Mazzari MA; Rebuzzi AG; Schiavoni G; Crea F
    J Cardiovasc Med (Hagerstown); 2008 Oct; 9(10):1004-10. PubMed ID: 18799962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Percutaneous left ventricular assist device for high-risk percutaneous coronary interventions: Real-world versus clinical trial experience.
    Cohen MG; Matthews R; Maini B; Dixon S; Vetrovec G; Wohns D; Palacios I; Popma J; Ohman EM; Schreiber T; O'Neill WW
    Am Heart J; 2015 Nov; 170(5):872-9. PubMed ID: 26542494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Surgical Consultation on Outcomes in Hemodynamically Supported High-Risk Percutaneous Coronary Intervention: Insights From PROTECT II Randomized Study.
    Shavelle DM; Kirtane AJ; Schreiber TL; Kapasi NK; O'Neill WW; Moses JW; Popma J; Matthews RV
    J Invasive Cardiol; 2016 May; 28(5):187-92. PubMed ID: 26887029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of atrial fibrillation in patients with ST-elevation myocardial infarction treated with percutaneous coronary intervention (from the HORIZONS-AMI [Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction] trial).
    Rene AG; Généreux P; Ezekowitz M; Kirtane AJ; Xu K; Mehran R; Brener SJ; Stone GW
    Am J Cardiol; 2014 Jan; 113(2):236-42. PubMed ID: 24176066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-risk percutaneous coronary intervention with the TandemHeart and Impella devices: a single-center experience.
    Schwartz BG; Ludeman DJ; Mayeda GS; Kloner RA; Economides C; Burstein S
    J Invasive Cardiol; 2011 Oct; 23(10):417-24. PubMed ID: 21972160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.